Namo Suksomyos

Experience

• 

  Chulalongkorn University

  Feb 2009 - May 2012

  Research and Teaching Assistant

  Conducted research resulting publication in internationally peer-reviewed journals;Chirathaworn C, Suksomyos N, Utivamek U, Keelawat S, Suwancharoen D, Phulsuksombati D, Yong Poovorawan. LipL21 mRNA expression in lungs of hamsters infected with pathogenic Leptospira. Asian Pacific J Trop Med 2009; 2(5); 8-13.Suksomyos N, Chanprasert S, Maunpasitporn C, Ponlapat Rojnuckarin. Prevalence of JAK2V617F Mutation and Its Clinical Correlation in Thais with Myeloproliferative Neoplasm. Int J Biol Med Res. 2012; 3(2): 1801-5. Show less

• 

  MP Group (Thailand)

  Jul 2012 - Jul 2015

  Drove the firm to claim Thailand’s top rapid testing for infectious diseases in terms of market share and top 3 in molecular diagnostics for microbiology, immunoassays for blood donor screening, and point-of-care testing for cardiac markers (Clearstate, 2016).

  • Assistant Marketing Manager

    Jan 2014 - Jul 2015

  • Clinical Marketing and Application Executive, Molecular Diagnostics

    Jul 2012 - Dec 2013
• 

  Werfen

  Aug 2015 - Jul 2018

  Streamlined marketing strategies and commercial operation between the US-based global business unit and distribution partners resulting 50+ installations, 2 of which are Total Lab Automation projects in Vietnam and the first installation in Singapore generating US$ 6M turnover (FY2017). Worked with KOLs within and outside the region to localise marketing messages resulting successful launches of ACL TOP50 Series, HemoCell & HemoHub, DOAC testing, liquid PT, and relaunch of ACL AcuStar.

  • Regional Product Manager - Southeast Asia

    Feb 2017 - Jul 2018

  • Regional Clinical Marketing Specialist - Southeast Asia

    Aug 2015 - Jan 2017
• 

  Grenoble Ecole de Management

  Sept 2018 - Jul 2020

  MBA Candidate
• 

  MP Group (Thailand)

  Sept 2019 - Feb 2021

  International Business Development Manager

  Shared half P&L responsibility of US$ 37.5M revenue focalising on COGS of Core Lab Diagnostics business. Liaised with the Principals abroad to allow for strategy alignment with local business units. Provided supervision over pre-markets activities and supply chain to ensure that the demands are met in a cost efficient manner resulting 45% EBITDA vs revenue (FY2020).

• 

  Abbott

  Feb 2021 - now

  Lead marketing strategies and initiatives for the responsible product franchise in Asia-Pacific. Work extensively with Global Marketing counterpart as well as Country Affiliates from global strategy to the regional equivalent until it is translated to execution in each respective market to allow for revenue achievement. Responsible for Abbott Rapid Diagnostic (ARDx) business in Thailand. Worked extensively with affiliates at the APAC level to tailor go-to-market strategy as well as regularly went in the field with distribution partners to ensure budget achievement.

  • Regional Product Manager, Asia-Pacific

    Jan 2023 - now

  • Senior Business Development Manager

    Dec 2021 - Dec 2022

  • Business Development Manager

    Feb 2021 - Dec 2021